MRC (UKRI)
Chemical, Biological, Radiological and Nuclear (CBRN) Medical Countermeasures R&D
16:00 UK time
Last seen in a scan/import: .
Catalog updated: .
These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.
This MRC (UKRI) call funds pre-clinical and early translational research developing medical countermeasures for chemical, biological, radiological and nuclear (CBRN) threats, covering work from prototype development through early-phase clinical trials up to phase 2a. It offers up to £4M full economic cost (MRC covers 80%) over projects lasting up to 30 months, and is open only to individual applicants employed at a UK-based eligible research organisation. Entry is invite-only: applicants must first submit an Expression of Interest and be invited to submit a full application.
Details
| Funder | MRC (UKRI) |
| Budget | Up to £4M FEC (MRC funds 80%) |
| Deadline | 20 January 2027 |
| Duration | Up to 30 months |
| Consortium | No - individual applicant, hosted by UK based eligible research organisation; project partners may contribute but cannot be project lead |
| Application | Invite-only: requires successful Expression of Interest before invited full application |
| Eligible countries | GB |
Eligibility & scope
Invite-only funding opportunity for pre-clinical and early translational research developing medical countermeasures for CBRN threats, from prototype development through early-phase clinical trials (up to phase 2a). Applicant must be employed by a UK-based eligible research organisation; international and commercial organisations cannot lead or co-lead.
Who Should Apply
- •Researchers employed by a UK-based eligible research organisation
- •Individual applicants leading pre-clinical or early translational projects (no joint lead)
- •Projects spanning prototype development through early-phase (up to phase 2a) clinical trials
- •Teams with potential project partners, including commercial or international collaborators, who can contribute but not lead
- •Researchers working on chemical, biological, radiological or nuclear threat countermeasures
Key Dates
- •Expression of Interest deadline: 20 January 2027, 16:00 UK time
- •Invite-only full application follows a successful Expression of Interest
- •Project duration up to 30 months
Tips for Applicants
- ✓Treat the Expression of Interest as the real gatekeeper, only successful EOIs are invited to submit a full application, so front-load feasibility and threat relevance there.
- ✓Clarify project partner roles early: international and commercial organisations can contribute funding or expertise but cannot be named as lead or co-lead.
- ✓Since MRC funds 80% FEC, confirm your host institution can cover the remaining 20% before committing to the EOI.
Frequently Asked Questions
How much funding does the MRC CBRN Medical Countermeasures call provide?
Up to £4M full economic cost, with MRC funding 80% of that amount.
Is this MRC CBRN call open to direct applications?
No, it is invite-only, applicants must first submit a successful Expression of Interest before being invited to apply in full.
Can international or commercial organisations lead a project in this call?
No, the lead applicant must be employed by a UK-based eligible research organisation, though international and commercial organisations can participate as project partners.
How long can a funded CBRN medical countermeasures project run?
Projects can run for up to 30 months.
What stage of research does this MRC call fund?
It funds pre-clinical and early translational research, from prototype development through early-phase clinical trials up to phase 2a.
Related on Grantsby
- MRC (UKRI) writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Chemical, Biological, Radiological and Nuclear (CBRN) Medical Countermeasures R&D
MRC (UKRI)Deadline: 20 Oct 2026Up to £4M (80% FEC)Proof of Concept
MRC (UKRI)Deadline: 18 Nov 2026No limit stated; 80% FEC fundedMRC Proof of Concept
MRC (UKRI)Deadline: 4 Nov 2026No limit stated; 80% FEC funded (100% for permitted exceptions)Experimental Medicine
MRC (UKRI)Deadline: 14 Apr 2027Drug Development Project
Cancer Research UK
Browse Related
Could Chemical, Biological, Radiological and Nuclear (CBRN) Medical Countermeasures R&D be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →